chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vitamin B6, Weight decreased, White blood cell count increased
Clinical narrative: Initially, I had moderate lymphadenopathy under my left arm. Over the next 2 weeks, I developed constant burning in my tongue and roof of my mouth. These symptoms progressively worsened over the next several months until it peaked in July, 2021. At that point, the burning was severe and constant. I also had progressively lost taste and developed a persistent metallic/salty taste. Additionally, I also began having parosmia and smelled fecal matter most of the time. These symptoms have persisted, but are improved as of 10/5/21 after having 12 sessions of acupuncture over the past 2 months. During late March to early May 2021, I also experienced fatigue, hair loss and easily bruised. I have lost 28 pounds since February due to inability to tolerate tastes and textures along with the burning sensation.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Eye swelling, Mouth swelling, Nausea, Pharyngeal swelling
Clinical narrative: I don't know if this has anything to do with the vaccine or not.  Also the dates given in this report may be approximate.  There are additional visits to ERs and DRs. not reported there.  No intent to mislead just hard to recall.   Before the vaccine I was having occasional idiopathic allergic reactions.  Since I have received the vaccine they have escalated in frequency and severity.  Terrible hives, itching, chest pain, nausea, vomiting and swelling of mouth eyes and throat.   Happening very frequently.  Sometimes multiple times a week.  Having to use epipens and going to the ER.   Initially thought to be associated with red wine or beer, possibly red meat but has since been shown to happen without those things on board.  Even after eating vegetarian for days.   Idiopathic and unpredictable.  Wondering if this has been reported by anyone else.   I have since had my second Pfizer shot on 2/21/21.   I do not regret getting the vaccines and plan on getting my booster 10/21/2021.  Again the dates are approximate and the medical visits are multiple.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria, Vomiting
Clinical narrative: I don't know if this has anything to do with the vaccine or not.  Also the dates given in this report may be approximate.  There are additional visits to ERs and DRs. not reported there.  No intent to mislead just hard to recall.   Before the vaccine I was having occasional idiopathic allergic reactions.  Since I have received the vaccine they have escalated in frequency and severity.  Terrible hives, itching, chest pain, nausea, vomiting and swelling of mouth eyes and throat.   Happening very frequently.  Sometimes multiple times a week.  Having to use epipens and going to the ER.   Initially thought to be associated with red wine or beer, possibly red meat but has since been shown to happen without those things on board.  Even after eating vegetarian for days.   Idiopathic and unpredictable.  Wondering if this has been reported by anyone else.   I have since had my second Pfizer shot on 2/21/21.   I do not regret getting the vaccines and plan on getting my booster 10/21/2021.  Again the dates are approximate and the medical visits are multiple.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrioventricular block second degree, Bradycardia, COVID-19, Cardiac imaging procedure abnormal, Cardioversion
Clinical narrative: patient presented to ED (discharged 1 week prior) with new fever, chills, n/v/body aches, sore throat.   Has no known history of prolonged QTc, and during beginning of admission, she was noted to have intermittent sinus bradycardia and prolonged QTc. On 8/16, rapid response was called for pause dependent R on P leading to TdP which required shocks x2, two rounds of CPR, and amiodarone. Likely her QTc prolongation and episode of TdP are multi-factorial in etiology with contributions from potential underlying genetic predisposition, QT-prolonging medications, transient electrolyte abnormalities iso HD, and bradycardia. In the context of her prolonged QTc and TdP, she was taken off multiple QT-prolonging medications, including quetiapine, citalopram, odansetron, compazine, and remdesivir, and she was initially treated with isoproterenol with goal HR >65. EP was consulted who felt that a PPM was not indicated and to instead pursue medical management. Since discontinuation of these medications and initiation of treatment, her QTc and bradycardia have improved. However, on 8/23 overnight she was noted to have newly prolonged PR interval that has persisted. Per EP, this is a rate dependent PR prolongation. 8/28 with 3-4 second pause on rhythm strip in setting of increased vagal tone with 2-3 p waves that did not conduct, suggestive of ongoing significant conductive disease. HR down to 30s in the evening, asymptomatic, sinus with rare Mobitz 1. Feel that this is likely due to myocarditis and not a consequence of steroids. PR interval now normalized and QTc as well in setting of bradycardia. 09/01, patient continues to be bradycardic (mid 40s - low 50s) but asymptomatic at rest or with exertion.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Condition aggravated, Conduction disorder, Disease susceptibility, Electrocardiogram PR prolongation
Clinical narrative: patient presented to ED (discharged 1 week prior) with new fever, chills, n/v/body aches, sore throat.   Has no known history of prolonged QTc, and during beginning of admission, she was noted to have intermittent sinus bradycardia and prolonged QTc. On 8/16, rapid response was called for pause dependent R on P leading to TdP which required shocks x2, two rounds of CPR, and amiodarone. Likely her QTc prolongation and episode of TdP are multi-factorial in etiology with contributions from potential underlying genetic predisposition, QT-prolonging medications, transient electrolyte abnormalities iso HD, and bradycardia. In the context of her prolonged QTc and TdP, she was taken off multiple QT-prolonging medications, including quetiapine, citalopram, odansetron, compazine, and remdesivir, and she was initially treated with isoproterenol with goal HR >65. EP was consulted who felt that a PPM was not indicated and to instead pursue medical management. Since discontinuation of these medications and initiation of treatment, her QTc and bradycardia have improved. However, on 8/23 overnight she was noted to have newly prolonged PR interval that has persisted. Per EP, this is a rate dependent PR prolongation. 8/28 with 3-4 second pause on rhythm strip in setting of increased vagal tone with 2-3 p waves that did not conduct, suggestive of ongoing significant conductive disease. HR down to 30s in the evening, asymptomatic, sinus with rare Mobitz 1. Feel that this is likely due to myocarditis and not a consequence of steroids. PR interval now normalized and QTc as well in setting of bradycardia. 09/01, patient continues to be bradycardic (mid 40s - low 50s) but asymptomatic at rest or with exertion.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram QT prolonged, Electrolyte imbalance, Haemodialysis, Heart rate decreased, Hydronephrosis
Clinical narrative: patient presented to ED (discharged 1 week prior) with new fever, chills, n/v/body aches, sore throat.   Has no known history of prolonged QTc, and during beginning of admission, she was noted to have intermittent sinus bradycardia and prolonged QTc. On 8/16, rapid response was called for pause dependent R on P leading to TdP which required shocks x2, two rounds of CPR, and amiodarone. Likely her QTc prolongation and episode of TdP are multi-factorial in etiology with contributions from potential underlying genetic predisposition, QT-prolonging medications, transient electrolyte abnormalities iso HD, and bradycardia. In the context of her prolonged QTc and TdP, she was taken off multiple QT-prolonging medications, including quetiapine, citalopram, odansetron, compazine, and remdesivir, and she was initially treated with isoproterenol with goal HR >65. EP was consulted who felt that a PPM was not indicated and to instead pursue medical management. Since discontinuation of these medications and initiation of treatment, her QTc and bradycardia have improved. However, on 8/23 overnight she was noted to have newly prolonged PR interval that has persisted. Per EP, this is a rate dependent PR prolongation. 8/28 with 3-4 second pause on rhythm strip in setting of increased vagal tone with 2-3 p waves that did not conduct, suggestive of ongoing significant conductive disease. HR down to 30s in the evening, asymptomatic, sinus with rare Mobitz 1. Feel that this is likely due to myocarditis and not a consequence of steroids. PR interval now normalized and QTc as well in setting of bradycardia. 09/01, patient continues to be bradycardic (mid 40s - low 50s) but asymptomatic at rest or with exertion.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Nausea, Nephrectomy, Nephrolithiasis, Oropharyngeal pain
Clinical narrative: patient presented to ED (discharged 1 week prior) with new fever, chills, n/v/body aches, sore throat.   Has no known history of prolonged QTc, and during beginning of admission, she was noted to have intermittent sinus bradycardia and prolonged QTc. On 8/16, rapid response was called for pause dependent R on P leading to TdP which required shocks x2, two rounds of CPR, and amiodarone. Likely her QTc prolongation and episode of TdP are multi-factorial in etiology with contributions from potential underlying genetic predisposition, QT-prolonging medications, transient electrolyte abnormalities iso HD, and bradycardia. In the context of her prolonged QTc and TdP, she was taken off multiple QT-prolonging medications, including quetiapine, citalopram, odansetron, compazine, and remdesivir, and she was initially treated with isoproterenol with goal HR >65. EP was consulted who felt that a PPM was not indicated and to instead pursue medical management. Since discontinuation of these medications and initiation of treatment, her QTc and bradycardia have improved. However, on 8/23 overnight she was noted to have newly prolonged PR interval that has persisted. Per EP, this is a rate dependent PR prolongation. 8/28 with 3-4 second pause on rhythm strip in setting of increased vagal tone with 2-3 p waves that did not conduct, suggestive of ongoing significant conductive disease. HR down to 30s in the evening, asymptomatic, sinus with rare Mobitz 1. Feel that this is likely due to myocarditis and not a consequence of steroids. PR interval now normalized and QTc as well in setting of bradycardia. 09/01, patient continues to be bradycardic (mid 40s - low 50s) but asymptomatic at rest or with exertion.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Postoperative ileus, Pyrexia, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: patient presented to ED (discharged 1 week prior) with new fever, chills, n/v/body aches, sore throat.   Has no known history of prolonged QTc, and during beginning of admission, she was noted to have intermittent sinus bradycardia and prolonged QTc. On 8/16, rapid response was called for pause dependent R on P leading to TdP which required shocks x2, two rounds of CPR, and amiodarone. Likely her QTc prolongation and episode of TdP are multi-factorial in etiology with contributions from potential underlying genetic predisposition, QT-prolonging medications, transient electrolyte abnormalities iso HD, and bradycardia. In the context of her prolonged QTc and TdP, she was taken off multiple QT-prolonging medications, including quetiapine, citalopram, odansetron, compazine, and remdesivir, and she was initially treated with isoproterenol with goal HR >65. EP was consulted who felt that a PPM was not indicated and to instead pursue medical management. Since discontinuation of these medications and initiation of treatment, her QTc and bradycardia have improved. However, on 8/23 overnight she was noted to have newly prolonged PR interval that has persisted. Per EP, this is a rate dependent PR prolongation. 8/28 with 3-4 second pause on rhythm strip in setting of increased vagal tone with 2-3 p waves that did not conduct, suggestive of ongoing significant conductive disease. HR down to 30s in the evening, asymptomatic, sinus with rare Mobitz 1. Feel that this is likely due to myocarditis and not a consequence of steroids. PR interval now normalized and QTc as well in setting of bradycardia. 09/01, patient continues to be bradycardic (mid 40s - low 50s) but asymptomatic at rest or with exertion.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sinus arrest, Sinus bradycardia, Torsade de pointes, Vomiting
Clinical narrative: patient presented to ED (discharged 1 week prior) with new fever, chills, n/v/body aches, sore throat.   Has no known history of prolonged QTc, and during beginning of admission, she was noted to have intermittent sinus bradycardia and prolonged QTc. On 8/16, rapid response was called for pause dependent R on P leading to TdP which required shocks x2, two rounds of CPR, and amiodarone. Likely her QTc prolongation and episode of TdP are multi-factorial in etiology with contributions from potential underlying genetic predisposition, QT-prolonging medications, transient electrolyte abnormalities iso HD, and bradycardia. In the context of her prolonged QTc and TdP, she was taken off multiple QT-prolonging medications, including quetiapine, citalopram, odansetron, compazine, and remdesivir, and she was initially treated with isoproterenol with goal HR >65. EP was consulted who felt that a PPM was not indicated and to instead pursue medical management. Since discontinuation of these medications and initiation of treatment, her QTc and bradycardia have improved. However, on 8/23 overnight she was noted to have newly prolonged PR interval that has persisted. Per EP, this is a rate dependent PR prolongation. 8/28 with 3-4 second pause on rhythm strip in setting of increased vagal tone with 2-3 p waves that did not conduct, suggestive of ongoing significant conductive disease. HR down to 30s in the evening, asymptomatic, sinus with rare Mobitz 1. Feel that this is likely due to myocarditis and not a consequence of steroids. PR interval now normalized and QTc as well in setting of bradycardia. 09/01, patient continues to be bradycardic (mid 40s - low 50s) but asymptomatic at rest or with exertion.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Aspartate aminotransferase increased, Asthenia, C-reactive protein increased, COVID-19, Chest X-ray
Clinical narrative: 81yr old female who presents to ED via private car with complaints of weakness.  Patient states she tested positive for covid today in the clinic and was discharged to home.  Patient states she received a call at home and was instructed to come to ED for fluids and admission due to kidney function.  Patient denies pain at this time.  States she just feels weak.  Patient states she received her covid vaccine in March. ED then hospitalized for 5 days. pneumonia, weakness, dehydration, elevated AST, elevated crp
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Dehydration, Fibrin D dimer, Pneumonia, Renal impairment, SARS-CoV-2 test positive
Clinical narrative: 81yr old female who presents to ED via private car with complaints of weakness.  Patient states she tested positive for covid today in the clinic and was discharged to home.  Patient states she received a call at home and was instructed to come to ED for fluids and admission due to kidney function.  Patient denies pain at this time.  States she just feels weak.  Patient states she received her covid vaccine in March. ED then hospitalized for 5 days. pneumonia, weakness, dehydration, elevated AST, elevated crp
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Contraception, Menstruation irregular
Clinical narrative: Period began within hours of receiving vaccine, despite never having period due to Depo Provera shot.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dysarthria, Fatigue, Hyperhidrosis, Lethargy
Clinical narrative: LAB went into the room to draw blood and the patient said she was very tired and she had just had a shot.  The patient started slurring her words, became sweaty, lethargic, and stated her chest was heavy, and her throat was tight. Provider Dr. was brought to the room to evaluate the patient and he ordered 50 mg of injectable Benadryl, IM which was administered.  Dr. also called a rapid response through our hospital system and that team came as well.  The rapid response team decided to also administer an epi pen 0.3mg IM. After this medication the patient said her throat and chest felt less tight and she started to feel better and the team decided she did not need another dose of epi.The patient was observed for 1 hour in the clinic per rapid response team and left on her own after that.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: LAB went into the room to draw blood and the patient said she was very tired and she had just had a shot.  The patient started slurring her words, became sweaty, lethargic, and stated her chest was heavy, and her throat was tight. Provider Dr. was brought to the room to evaluate the patient and he ordered 50 mg of injectable Benadryl, IM which was administered.  Dr. also called a rapid response through our hospital system and that team came as well.  The rapid response team decided to also administer an epi pen 0.3mg IM. After this medication the patient said her throat and chest felt less tight and she started to feel better and the team decided she did not need another dose of epi.The patient was observed for 1 hour in the clinic per rapid response team and left on her own after that.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood test, Cold sweat, Headache
Clinical narrative: Elevated blood pressure, head aches, clammy feeling.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Chest discomfort, Electrocardiogram, Extra dose administered, Headache
Clinical narrative: Elevated blood pressure, head aches, clammy feeling.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test
Clinical narrative: Elevated blood pressure, head aches, clammy feeling.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Contusion, Hypoaesthesia, Injection site bruising, Injection site hypoaesthesia
Clinical narrative: Normal side effect at first with an extremely sore arm. A bruise the size of a nickel. Since day 3 aching in the left arm, weakness in that arm, numbness in my left hand. Now 4 weeks later I still have the aching, numbness, bruise and a large dent in my muscle in left arm at location of vaccine.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site indentation, Injection site pain, Pain in extremity
Clinical narrative: Normal side effect at first with an extremely sore arm. A bruise the size of a nickel. Since day 3 aching in the left arm, weakness in that arm, numbness in my left hand. Now 4 weeks later I still have the aching, numbness, bruise and a large dent in my muscle in left arm at location of vaccine.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, Illness
Clinical narrative: Illness and death related to COVID.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pt received Pfizer x2.  Pt tested COVID + on 10/1/21 and admitted to hospital for COVID on 10/1/2021. Pt receiving remdesivir and dexamethasone.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Anion gap decreased, Blood calcium normal, Blood chloride increased, Blood creatinine normal, Blood glucose normal
Clinical narrative: HPI: This is a 17-year-old female brought in by mother presenting with syncope that was not witnessed earlier today.  Currently, patient endorses moderate and constant dizziness and shakiness.  Patient received her first dose of the Pfizer COVID-19 vaccination yesterday and currently endorses right upper arm pain.  Reexamination/Reevaluation  10/03/21 18:04:34 - I have reevaluated the patient at this time who states pain and symptoms have improved and requests to be discharged home at this time. Pt understands the findings of their studies completed today. Patient appears stable for discharge.  I discussed with her and her grandmother the need to start iron pills and all of the symptoms that, starting iron pills.  She was discharged with iron pills and constipation medications.  She is aware that her stool may change and also get darker.  She is aware that she needs to follow-up with a primary care doctor to get repeat blood tests.  We discussed all return precautions as well. Medical Decision Making  Based on H&P and testing, this patient?s microcytic anemia appears to be amenable for outpatient treatment.  Patient has not received a blood transfusion in the ED. The patient is at low risk for life threatening hemorrhage or secondary complications of anemia such as acute coronary syndrome etc.  The patient has been given strict return precautions and understands the need for further outpatient testing and treatment. Likely cause of mild anemia is menses.  After consideration of a broader differential, patient was diagnosed with weakness, dizziness, and postvaccination reaction and will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing and well hydrated. Patient?s symptoms not typical for other emergent causes that require further testing or treatment in the ED.  It was explained to patient that some disease processes can evolve over time. Although the patient does not have the signs and symptoms to indicate an emergent diagnosis at this time, the patient was made aware that this is a possibility in the future.  The patient was given strict return precautions and will follow up with primary MD in 1-2 days for further evaluation. Diagnosis/Assessment/Plan  1. Mild anemia  2. Shakiness  3. Dizziness  4. Post-vaccination reaction
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea normal, Carbon dioxide normal, Chest X-ray normal
Clinical narrative: HPI: This is a 17-year-old female brought in by mother presenting with syncope that was not witnessed earlier today.  Currently, patient endorses moderate and constant dizziness and shakiness.  Patient received her first dose of the Pfizer COVID-19 vaccination yesterday and currently endorses right upper arm pain.  Reexamination/Reevaluation  10/03/21 18:04:34 - I have reevaluated the patient at this time who states pain and symptoms have improved and requests to be discharged home at this time. Pt understands the findings of their studies completed today. Patient appears stable for discharge.  I discussed with her and her grandmother the need to start iron pills and all of the symptoms that, starting iron pills.  She was discharged with iron pills and constipation medications.  She is aware that her stool may change and also get darker.  She is aware that she needs to follow-up with a primary care doctor to get repeat blood tests.  We discussed all return precautions as well. Medical Decision Making  Based on H&P and testing, this patient?s microcytic anemia appears to be amenable for outpatient treatment.  Patient has not received a blood transfusion in the ED. The patient is at low risk for life threatening hemorrhage or secondary complications of anemia such as acute coronary syndrome etc.  The patient has been given strict return precautions and understands the need for further outpatient testing and treatment. Likely cause of mild anemia is menses.  After consideration of a broader differential, patient was diagnosed with weakness, dizziness, and postvaccination reaction and will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing and well hydrated. Patient?s symptoms not typical for other emergent causes that require further testing or treatment in the ED.  It was explained to patient that some disease processes can evolve over time. Although the patient does not have the signs and symptoms to indicate an emergent diagnosis at this time, the patient was made aware that this is a possibility in the future.  The patient was given strict return precautions and will follow up with primary MD in 1-2 days for further evaluation. Diagnosis/Assessment/Plan  1. Mild anemia  2. Shakiness  3. Dizziness  4. Post-vaccination reaction
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Haematocrit decreased, Haemoglobin decreased, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin decreased
Clinical narrative: HPI: This is a 17-year-old female brought in by mother presenting with syncope that was not witnessed earlier today.  Currently, patient endorses moderate and constant dizziness and shakiness.  Patient received her first dose of the Pfizer COVID-19 vaccination yesterday and currently endorses right upper arm pain.  Reexamination/Reevaluation  10/03/21 18:04:34 - I have reevaluated the patient at this time who states pain and symptoms have improved and requests to be discharged home at this time. Pt understands the findings of their studies completed today. Patient appears stable for discharge.  I discussed with her and her grandmother the need to start iron pills and all of the symptoms that, starting iron pills.  She was discharged with iron pills and constipation medications.  She is aware that her stool may change and also get darker.  She is aware that she needs to follow-up with a primary care doctor to get repeat blood tests.  We discussed all return precautions as well. Medical Decision Making  Based on H&P and testing, this patient?s microcytic anemia appears to be amenable for outpatient treatment.  Patient has not received a blood transfusion in the ED. The patient is at low risk for life threatening hemorrhage or secondary complications of anemia such as acute coronary syndrome etc.  The patient has been given strict return precautions and understands the need for further outpatient testing and treatment. Likely cause of mild anemia is menses.  After consideration of a broader differential, patient was diagnosed with weakness, dizziness, and postvaccination reaction and will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing and well hydrated. Patient?s symptoms not typical for other emergent causes that require further testing or treatment in the ED.  It was explained to patient that some disease processes can evolve over time. Although the patient does not have the signs and symptoms to indicate an emergent diagnosis at this time, the patient was made aware that this is a possibility in the future.  The patient was given strict return precautions and will follow up with primary MD in 1-2 days for further evaluation. Diagnosis/Assessment/Plan  1. Mild anemia  2. Shakiness  3. Dizziness  4. Post-vaccination reaction
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Mean cell volume decreased, Mean platelet volume increased, Microcytic anaemia, Pain in extremity, Platelet count normal
Clinical narrative: HPI: This is a 17-year-old female brought in by mother presenting with syncope that was not witnessed earlier today.  Currently, patient endorses moderate and constant dizziness and shakiness.  Patient received her first dose of the Pfizer COVID-19 vaccination yesterday and currently endorses right upper arm pain.  Reexamination/Reevaluation  10/03/21 18:04:34 - I have reevaluated the patient at this time who states pain and symptoms have improved and requests to be discharged home at this time. Pt understands the findings of their studies completed today. Patient appears stable for discharge.  I discussed with her and her grandmother the need to start iron pills and all of the symptoms that, starting iron pills.  She was discharged with iron pills and constipation medications.  She is aware that her stool may change and also get darker.  She is aware that she needs to follow-up with a primary care doctor to get repeat blood tests.  We discussed all return precautions as well. Medical Decision Making  Based on H&P and testing, this patient?s microcytic anemia appears to be amenable for outpatient treatment.  Patient has not received a blood transfusion in the ED. The patient is at low risk for life threatening hemorrhage or secondary complications of anemia such as acute coronary syndrome etc.  The patient has been given strict return precautions and understands the need for further outpatient testing and treatment. Likely cause of mild anemia is menses.  After consideration of a broader differential, patient was diagnosed with weakness, dizziness, and postvaccination reaction and will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing and well hydrated. Patient?s symptoms not typical for other emergent causes that require further testing or treatment in the ED.  It was explained to patient that some disease processes can evolve over time. Although the patient does not have the signs and symptoms to indicate an emergent diagnosis at this time, the patient was made aware that this is a possibility in the future.  The patient was given strict return precautions and will follow up with primary MD in 1-2 days for further evaluation. Diagnosis/Assessment/Plan  1. Mild anemia  2. Shakiness  3. Dizziness  4. Post-vaccination reaction
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cell count normal, Red cell distribution width increased, Syncope, Tremor, Troponin I normal
Clinical narrative: HPI: This is a 17-year-old female brought in by mother presenting with syncope that was not witnessed earlier today.  Currently, patient endorses moderate and constant dizziness and shakiness.  Patient received her first dose of the Pfizer COVID-19 vaccination yesterday and currently endorses right upper arm pain.  Reexamination/Reevaluation  10/03/21 18:04:34 - I have reevaluated the patient at this time who states pain and symptoms have improved and requests to be discharged home at this time. Pt understands the findings of their studies completed today. Patient appears stable for discharge.  I discussed with her and her grandmother the need to start iron pills and all of the symptoms that, starting iron pills.  She was discharged with iron pills and constipation medications.  She is aware that her stool may change and also get darker.  She is aware that she needs to follow-up with a primary care doctor to get repeat blood tests.  We discussed all return precautions as well. Medical Decision Making  Based on H&P and testing, this patient?s microcytic anemia appears to be amenable for outpatient treatment.  Patient has not received a blood transfusion in the ED. The patient is at low risk for life threatening hemorrhage or secondary complications of anemia such as acute coronary syndrome etc.  The patient has been given strict return precautions and understands the need for further outpatient testing and treatment. Likely cause of mild anemia is menses.  After consideration of a broader differential, patient was diagnosed with weakness, dizziness, and postvaccination reaction and will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing and well hydrated. Patient?s symptoms not typical for other emergent causes that require further testing or treatment in the ED.  It was explained to patient that some disease processes can evolve over time. Although the patient does not have the signs and symptoms to indicate an emergent diagnosis at this time, the patient was made aware that this is a possibility in the future.  The patient was given strict return precautions and will follow up with primary MD in 1-2 days for further evaluation. Diagnosis/Assessment/Plan  1. Mild anemia  2. Shakiness  3. Dizziness  4. Post-vaccination reaction
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: HPI: This is a 17-year-old female brought in by mother presenting with syncope that was not witnessed earlier today.  Currently, patient endorses moderate and constant dizziness and shakiness.  Patient received her first dose of the Pfizer COVID-19 vaccination yesterday and currently endorses right upper arm pain.  Reexamination/Reevaluation  10/03/21 18:04:34 - I have reevaluated the patient at this time who states pain and symptoms have improved and requests to be discharged home at this time. Pt understands the findings of their studies completed today. Patient appears stable for discharge.  I discussed with her and her grandmother the need to start iron pills and all of the symptoms that, starting iron pills.  She was discharged with iron pills and constipation medications.  She is aware that her stool may change and also get darker.  She is aware that she needs to follow-up with a primary care doctor to get repeat blood tests.  We discussed all return precautions as well. Medical Decision Making  Based on H&P and testing, this patient?s microcytic anemia appears to be amenable for outpatient treatment.  Patient has not received a blood transfusion in the ED. The patient is at low risk for life threatening hemorrhage or secondary complications of anemia such as acute coronary syndrome etc.  The patient has been given strict return precautions and understands the need for further outpatient testing and treatment. Likely cause of mild anemia is menses.  After consideration of a broader differential, patient was diagnosed with weakness, dizziness, and postvaccination reaction and will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing and well hydrated. Patient?s symptoms not typical for other emergent causes that require further testing or treatment in the ED.  It was explained to patient that some disease processes can evolve over time. Although the patient does not have the signs and symptoms to indicate an emergent diagnosis at this time, the patient was made aware that this is a possibility in the future.  The patient was given strict return precautions and will follow up with primary MD in 1-2 days for further evaluation. Diagnosis/Assessment/Plan  1. Mild anemia  2. Shakiness  3. Dizziness  4. Post-vaccination reaction
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Computerised tomogram, Ultrasound scan
Clinical narrative: Chest tightness
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Dermatitis, Peripheral swelling, Pruritus, Rash
Clinical narrative: Full body skin rash, dermatitis with blisters and itch.  Swollen fingers from the reaction also.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chest X-ray, Injection site haemorrhage, Laboratory test, Myalgia
Clinical narrative: Bleeding from injection site.  Concern that the injection was done in the wrong place (it was not done in our office.)  Severe muscle pain and joint pain,  with moderate widespread pain, especially chest wall pain, persisting > 5 weeks so far.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Bleeding from injection site.  Concern that the injection was done in the wrong place (it was not done in our office.)  Severe muscle pain and joint pain,  with moderate widespread pain, especially chest wall pain, persisting > 5 weeks so far.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Admitted to Hospital on Date of Adverse Event [recorded in VAERS] for treatment of Covid-19 Positive following completion of Covid Vaccine Series
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac assistance device user, Cardiac imaging procedure abnormal, Cardiac stress test, Heart rate increased, Laboratory test
Clinical narrative: Patient experienced rapid heart rate starting on May 25, 2021.  I took him to the ER on May 26, 2021.  They tried a couple of different methods to get his heart rate back to normal and were finally successful after shocking his heart.  They administered several tests to find out why his heart rhythm had been so fast.  They diagnosed him as having acute idopathic myocarditis.  He was placed on Metoprolol for 3 months and fitted for a Life Vest that he wore for 30 days.  On June 28th, patient had another MRI and it showed that the myocarditis was reduced.  He continued with the Metoprolol.  On September 3rd, he took a heart stress test, and was allowed to go off of the Metoprolol.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Myocarditis
Clinical narrative: Patient experienced rapid heart rate starting on May 25, 2021.  I took him to the ER on May 26, 2021.  They tried a couple of different methods to get his heart rate back to normal and were finally successful after shocking his heart.  They administered several tests to find out why his heart rhythm had been so fast.  They diagnosed him as having acute idopathic myocarditis.  He was placed on Metoprolol for 3 months and fitted for a Life Vest that he wore for 30 days.  On June 28th, patient had another MRI and it showed that the myocarditis was reduced.  He continued with the Metoprolol.  On September 3rd, he took a heart stress test, and was allowed to go off of the Metoprolol.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Heart rate increased, Palpitations
Clinical narrative: Within seconds, I could start feeling my heart race and they told me to sit down for 15 minutes. I sat there for 20 minutes hoping it would go away. It didn't. I started walking away but went back in and reported it and they brought people to evaluate me. My heart rate and blood pressure were elevated. They brought in someone from the  St Joseph Medical Center ER dept and that person decided I needed to go over and be admitted to ER. I stayed there for 3-4 hours before it finally came down and they let me go home. No treatment at that time - just observed me. I did not experience re-occurrence of symptoms.  I went to see my doctor to follow up and she said everything was okay. I had different medical tests related to my asthma.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest discomfort, Chills, Cough, Crying
Clinical narrative: Unusual and unexpected side effects of the vaccine. About 12 hours after vaccine administration: waking through the night, irritability and crying, overly frequent need to pee (within 30 seconds of fluid intake & at least once every 2 hours) ? along with the more common side effects body aching, weakness, soreness at injection site, and fever.  Within 24 hours of receiving the vaccine, also experienced parosmia & ensuing total loss of appetite, severe malaise (urge to shiver, chest discomfort resulting in urge to cough), and the more common side effects fatigue and headaches.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Injection site pain, Irritability
Clinical narrative: Unusual and unexpected side effects of the vaccine. About 12 hours after vaccine administration: waking through the night, irritability and crying, overly frequent need to pee (within 30 seconds of fluid intake & at least once every 2 hours) ? along with the more common side effects body aching, weakness, soreness at injection site, and fever.  Within 24 hours of receiving the vaccine, also experienced parosmia & ensuing total loss of appetite, severe malaise (urge to shiver, chest discomfort resulting in urge to cough), and the more common side effects fatigue and headaches.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain, Parosmia, Pollakiuria, Pyrexia
Clinical narrative: Unusual and unexpected side effects of the vaccine. About 12 hours after vaccine administration: waking through the night, irritability and crying, overly frequent need to pee (within 30 seconds of fluid intake & at least once every 2 hours) ? along with the more common side effects body aching, weakness, soreness at injection site, and fever.  Within 24 hours of receiving the vaccine, also experienced parosmia & ensuing total loss of appetite, severe malaise (urge to shiver, chest discomfort resulting in urge to cough), and the more common side effects fatigue and headaches.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Unusual and unexpected side effects of the vaccine. About 12 hours after vaccine administration: waking through the night, irritability and crying, overly frequent need to pee (within 30 seconds of fluid intake & at least once every 2 hours) ? along with the more common side effects body aching, weakness, soreness at injection site, and fever.  Within 24 hours of receiving the vaccine, also experienced parosmia & ensuing total loss of appetite, severe malaise (urge to shiver, chest discomfort resulting in urge to cough), and the more common side effects fatigue and headaches.
Age: 65.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Large area of redness, swelling, warmth, and itching at site of injection starting 7 days later.  Treated with a 5-day course of cephalexin, oral antihistamine, and topical cortisone cream.  Slight pinkness remains 1 week after onset; all other symptoms have resolved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Amenorrhoea, Pregnancy test negative
Clinical narrative: Absent period
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Candida infection, Culture throat, Dehydration, Extra dose administered, Oropharyngeal pain
Clinical narrative: Thrush(yeast infection in throat and mouth) recurred one month after 3rd vaccine.  Prior incident of thrush occurred on 7/19/21, which was 5 months after 2nd vaccine.  The July 2021 incident caused sore throat and fever (treated with Nystatin after urgent care visit), but after treatment failure led to dehydration and ER visit, then 2-week course of fluconazole.  The September 2021 incident was recognized by us more quickly, we went to urgent care and started 7-day course of fluconazole, which seems to have resolved the problem.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: Thrush(yeast infection in throat and mouth) recurred one month after 3rd vaccine.  Prior incident of thrush occurred on 7/19/21, which was 5 months after 2nd vaccine.  The July 2021 incident caused sore throat and fever (treated with Nystatin after urgent care visit), but after treatment failure led to dehydration and ER visit, then 2-week course of fluconazole.  The September 2021 incident was recognized by us more quickly, we went to urgent care and started 7-day course of fluconazole, which seems to have resolved the problem.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death
Clinical narrative: COVID illness and death.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (temperature)-
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID 10/2/21 after being fully vaccinated.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough COVID
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Enlarged uvula, Pharyngeal swelling, Physical examination
Clinical narrative: My uvula and the left side of my throat swelled and become one big structure.
Age: 49.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Within 12 hours of getting the vaccine, I had COVID.  You lied when you said it wasn't in the vaccine!!!
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary mass, Mammogram
Clinical narrative: Next day after first injection noticed axillary lump waited until September 21, 2021 to have mammogram.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Red, hot, swollen at injection site
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash, Rash erythematous
Clinical narrative: Allergic reaction, redness rash over abdomen, neck, face and down the legs. Benadryl did not work. Rash lasted for a week.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chills, Electrocardiogram normal
Clinical narrative: HE RECEIVED THE COVID VACCINE AT APPROX 11:00 AM ON 4 OCT 2021.  HE FELT FINE UNTIL HE AWOKE AT APPROX 2:00 AM ON 5 OCT 2021 WITH RIGORS.  HE WENT TO THE ER AT  HOSPITAL AND CHEST X-RAY AND EKG WERE UNREMARKABLE.  LABS WERE NOT COLLECTED.  HE WAS DISCHARGED TO HOME AND RECOMMENDED TO TAKE TYLENOL TO TREAT.  I SPOKE WITH HIM AT 4:00 PM ON 5 OCT 2021 AND THE RIGORS HAVE STOPPED, HE IS OTHERWISE FEELING OKAY.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event, COVID-19, SARS-CoV-2 test positive
Clinical narrative: Admitted to Hospital on Date of Adverse Event [recorded in VAERS] for treatment of Covid-19 Positive following completion of Covid Vaccine Series
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Disorientation, Hypotension, Sluggishness
Clinical narrative: Patient became very sluggish and a little disoriented. Blood pressure was severly low. Patient was monitored in urgent care.  EMS was called. Patient refused treatment
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose abnormal, Blood glucose increased, Chills, Myalgia
Clinical narrative: PATIENT EXPIERENCED SEVERE CHILLS, MUSCLE PAIN AND VERY HIGH BLOOD SUGAR (300+)
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dizziness, Fatigue, Full blood count, Pain in extremity
Clinical narrative: Lightheadedness, worsened fatigue, shaky-intermittent, lower extremity achiness-bilateral
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Lightheadedness, worsened fatigue, shaky-intermittent, lower extremity achiness-bilateral
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ageusia, Discomfort, Extra dose administered, Lip swelling, Oral discomfort
Clinical narrative: After the third injection - the next evening, tongue and mouth felt funny.  Can't taste anything, inside of lips feel swollen, tongue feels swollen and coated.  Ridges along sides of tongue.  Very uncomfortable.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Scalloped tongue, Swollen tongue, Tongue coated, Tongue discomfort
Clinical narrative: After the third injection - the next evening, tongue and mouth felt funny.  Can't taste anything, inside of lips feel swollen, tongue feels swollen and coated.  Ridges along sides of tongue.  Very uncomfortable.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: none, patient tolerated vaccine without any problems
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site mass, Injection site swelling, Pain
Clinical narrative: on 10/02/21 Noticed redness, swelling lump size of tennis ball at injection site. Had fatigue and body aches
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Two weeks after 1st dose on 03/22/2021 I experienced vertigo and I continued having vertigo for about a week after that. I normally see a chiropractor and so I did see him three times that week and he tried to help me with that because we didn't know what it was from.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Diarrhoea, Fatigue, Hyperhidrosis
Clinical narrative: 8-3-21, 7:00 pm, flu -like symptoms,  extremely tired.  8-04-21  - , diarrhea,  fever, chills, sweating. lost sense of taste., glands under arms swollen  Fever and chills -- chills - sweating soaking clothing and bed sheets for two nights. Diarrhea continued unit 8-7-21 Sense of taste gradually returned on 8-6-21 Glands swollen for about 10 days.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lymphadenopathy, Night sweats, Pyrexia
Clinical narrative: 8-3-21, 7:00 pm, flu -like symptoms,  extremely tired.  8-04-21  - , diarrhea,  fever, chills, sweating. lost sense of taste., glands under arms swollen  Fever and chills -- chills - sweating soaking clothing and bed sheets for two nights. Diarrhea continued unit 8-7-21 Sense of taste gradually returned on 8-6-21 Glands swollen for about 10 days.